Together, we can help find answers
With a confirmed diagnosis of autism risk from Marvel Genomics™, children as young as 18 months old can take the first steps towards improved outcomes.
A Lifelong Journey of Learning – Together
Introducing SMASH Genomic Assay: a quicker, more accurate proprietary test for detecting Copy Number Variation to help you diagnose ASD – and lead your patients to effective early therapies.
Together, We Can Help Find Answers
Marvel Genomics has developed the SMASH Genomic Assay, a Copy Number Variation test using next generation sequencing technology to help you diagnose ASD and take the first steps towards improved outcomes.
“My son’s diagnosis of autism led me to research the genetics of autism.
In 2015, I co-founded Marvel Genomics to help provide families like mine with the answers they need.”
Michael Ronemus, Ph.D., Co-Founder and Chief Scientific Officer Marvel Genomics